BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16055705)

  • 1. Identification of splicing silencers and enhancers in sense Alus: a role for pseudoacceptors in splice site repression.
    Lei H; Vorechovsky I
    Mol Cell Biol; 2005 Aug; 25(16):6912-20. PubMed ID: 16055705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition.
    Královicová J; Vorechovsky I
    Nucleic Acids Res; 2007; 35(19):6399-413. PubMed ID: 17881373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intronic antisense Alu elements have a negative splicing effect on the inclusion of adjacent downstream exons.
    Nakama M; Otsuka H; Ago Y; Sasai H; Abdelkreem E; Aoyama Y; Fukao T
    Gene; 2018 Jul; 664():84-89. PubMed ID: 29698748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex expression pattern of RPGR reveals a role for purine-rich exonic splicing enhancers.
    Hong DH; Li T
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3373-82. PubMed ID: 12407146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation of 5' and 3' processing sites as well as intron and exon sequences in calcitonin exon recognition.
    Zandberg H; Moen TC; Baas PD
    Nucleic Acids Res; 1995 Jan; 23(2):248-55. PubMed ID: 7862529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The birth of an alternatively spliced exon: 3' splice-site selection in Alu exons.
    Lev-Maor G; Sorek R; Shomron N; Ast G
    Science; 2003 May; 300(5623):1288-91. PubMed ID: 12764196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational analysis of splicing errors and mutations in human transcripts.
    Kurmangaliyev YZ; Gelfand MS
    BMC Genomics; 2008 Jan; 9():13. PubMed ID: 18194514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transposable elements in disease-associated cryptic exons.
    Vorechovsky I
    Hum Genet; 2010 Feb; 127(2):135-54. PubMed ID: 19823873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
    Habara Y; Doshita M; Hirozawa S; Yokono Y; Yagi M; Takeshima Y; Matsuo M
    J Biochem; 2008 Mar; 143(3):303-10. PubMed ID: 18039686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers.
    Ibrahim EC; Schaal TD; Hertel KJ; Reed R; Maniatis T
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5002-7. PubMed ID: 15753297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exonization of AluYa5 in the human ACE gene requires mutations in both 3' and 5' splice sites and is facilitated by a conserved splicing enhancer.
    Lei H; Day IN; Vorechovský I
    Nucleic Acids Res; 2005; 33(12):3897-906. PubMed ID: 16027113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal conditions for exonization of intronic sequences: 5' splice site formation in alu exons.
    Sorek R; Lev-Maor G; Reznik M; Dagan T; Belinky F; Graur D; Ast G
    Mol Cell; 2004 Apr; 14(2):221-31. PubMed ID: 15099521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-causing mutations improving the branch site and polypyrimidine tract: pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail.
    Meili D; Kralovicova J; Zagalak J; Bonafé L; Fiori L; Blau N; Thöny B; Vorechovsky I
    Hum Mutat; 2009 May; 30(5):823-31. PubMed ID: 19280650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential nucleotides direct neuron-specific splicing of gamma 2 pre-mRNA.
    Zhang L; Ashiya M; Sherman TG; Grabowski PJ
    RNA; 1996 Jul; 2(7):682-98. PubMed ID: 8756411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine-rich exon sequences are not necessarily splicing enhancer sequence in the dystrophin gene.
    Ito T; Takeshima Y; Sakamoto H; Nakamura H; Matsuo M
    Kobe J Med Sci; 2001 Oct; 47(5):193-202. PubMed ID: 11781497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.
    Zheng ZM; Reid ES; Baker CC
    J Virol; 2000 Nov; 74(22):10612-22. PubMed ID: 11044105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in sequence and organization of splicing regulatory elements in vertebrate genes.
    Yeo G; Hoon S; Venkatesh B; Burge CB
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15700-5. PubMed ID: 15505203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
    Ashiya M; Grabowski PJ
    RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.